Premier Alternatives

Andson Biotech

Atlanta, GA · Founded 2020 · Privately Held (backing)

Developer of a novel Process Analytical Technology (PAT) designed for cell-based bioprocesses. Andson Biotech is based in Atlanta, GA and was founded in 2020. It was valued at $17.5 million at its seed round in Oct 2025, the last priced event on record. It has raised $9 million across 2 recorded rounds; the latest was a $4.7 million seed round in Oct 2025.

PMV mark · valuation
$17.5M
Oct 2026
Priced at
its seed round
Oct 2025
Total raised
$9.0M
Last round
Seed Round
Oct 2025

Andson Biotech key facts

as of Oct 2026
  • Developer of a novel Process Analytical Technology (PAT) designed for cell-based bioprocesses.
  • Andson Biotech is valued at approximately $17.5M as of Oct 2026, set at its seed round, Oct 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $9.0M across 2 recorded rounds; the latest was Seed Round ($4.7M) in Oct 2025.
  • Notable investors include Y Combinator, MedTech Innovator, Gaingels, BioTools Innovator, Biolocity — 10 tracked in total.
  • Andson Biotech has filed 1 Form D with the SEC, most recently Mar 2024 ($3.6M sold to 37 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$17.5M

Valued at $17.5M at its seed round, Oct 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Andson Biotech with a free account
  • ·Watch Andson Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Andson Biotech funding rounds

2 rounds
Oct 2025Seed Round$4.7MSEC filing▮
Mar 2024Seed Round$3.6MSEC filing▮
Full funding history →

Andson Biotech valuation

Andson Biotech was valued at $17.5 million at its seed round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Andson Biotech raised?

Andson Biotech has raised $9 million across 2 recorded rounds since 2024. The largest was a $4.7 million seed round in Oct 2025.

Andson Biotech has filed 1 Form D with the SEC, most recently in Mar 2024 ($3.6 million sold to 37 investors).

Andson Biotech investors

10 investors are on record for Andson Biotech, including Y Combinator, MedTech Innovator, Gaingels and BioTools Innovator. The seed round in Oct 2025 drew 29 investors.

About Andson Biotech

Developer of a novel Process Analytical Technology (PAT) designed for cell-based bioprocesses. The company uses a secretome analysis system and its core technologies to accelerate and simplify common analytical measurements carried out by conventional mass spec workflows and develops assays to telescope the drug discovery process and get advanced therapies to market, enabling healthcare professionals with recombinant proteins, monoclonal antibodies, and vaccines.

Sector
Healthcare
HQ
Atlanta, GA, United States
Founded
2020
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.